Cipher Pharmaceuticals' Natroba granted Medicaid preferred status in Illinois
Cipher Pharmaceuticals (TSX:CPH), a profitable specialty pharma company, reports that its Natroba treatment for scabies and head lice has been upgraded to preferred status by the state of Illinois
Concurrently, the state has downgraded Natroba's main competitor, Permethrin 5%, to non-preferred status
Cipher is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology
Cipher Pharmaceuticals stock has added 50.23 per cent year-over-year and 1,322.22 per cent since 2020
Cipher Pharmaceuticals (TSX:CPH), a profitable specialty pharma company, reports that its Natroba treatment for scabies and head lice has been upgraded to preferred status by the state of Illinois. Concurrently, the state has downgraded Natroba's main competitor, Permethrin 5%, to non-preferred status.
According to Tuesday's news release, the changes mean that 'all Medicaid treatments for scabies and Permethrin 5% prescriptions in the state must first step through Natroba being the preferred treatment in Illinois.'
The company believes that recent studies showing parasitic resistance to Permethrin played a determining factor in the updated preferred drug listing. See work by Rinaldi and Simonart for further reference.
Cipher has delivered positive net income over the past five fiscal years, with a high of US$26.64 million in 2022, and grew revenue by 58 per cent in 2024 thanks to increasing market share and the acquisition of Natroba. Investors have collected an over 1,300 per cent return since 2020. Leadership insights
'The medical decision made by the state of Illinois is just another example of the effectiveness of Natroba (Spinosad) and what clear growth potential for the product remains ahead of us,' Craig Mull, Cipher Pharmaceuticals' interim chief executive officer, said in a statement. 'We believe it is only a matter of time until more state pharmacy directors require step-through of Natroba representing the standard of care in the treatment of scabies and head lice. We are in active discussions with other U.S. states to build upon this recent success, and we continue to believe there is significant potential outside the U.S. to out-license Natroba whereby lice resistance to Permethrin-based products is a pervasive worldwide issue and whereby Natroba fills an unmet need.' About Cipher Pharmaceuticals
Cipher is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The company markets its products in Canada, South America and the United States.
Cipher Pharmaceuticals stock (TSX:CPH) is up by 3.31 per cent on the news trading at C$12.80 as of 10:01 am. The stock has added 50.23 per cent year-over-year and 1,322.22 per cent since 2020.
Join the discussion: Find out what everybody's saying about this pharmaceuticals stock on the Cipher Pharmaceuticals Inc. Bullboard and check out Stockhouse's stock forums and message boards.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
(Top photo: Cipher Pharmaceuticals)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Market Online
8 hours ago
- The Market Online
Weekend sampler: 3 micro-cap stocks to watch
With the TSX up by 5.7 per cent over the past month, just shy of its all-time-high, driven by a rebound in the price of oil, and the S&P 500 following suit, up by 6.8 per cent, emboldened by strong U.S. jobs data, investors are growing increasingly immune to Trump's tariff bluster. They're realizing that he's but one among many short-term headwinds, along with wars, recessions and a diversity of cultural conflicts, which stocks have proven more than capable of overcoming on their way to delivering attractive long-term returns. While financial media has a vested interest in making you worry about next quarter's earnings or the effects of a single central bank interest rate decision, fundamentals and value will always prevail in the end. This means it's always the right time to consider stocks with the potential to reward patient investors, grounded in the understanding that short-term volatility is the price of long-term gains. To this end, as you kick your feet up and kick off the well-deserved weekend, here are three fundamentally attractive micro-cap stocks for your perusing pleasure, each of them worth a deep dive towards a potential investment thanks to positive earnings per share year-over-year and evidence for keeping the profits flowing into the future. BQE Water Our first micro-cap stock pick, BQE Water (TSXV:BQE), market cap C$65.93 million, last trading at C$51 per share, specializes in water treatment and management for the mining, smelting and refining markets. Although the stock has added 363 per cent since 2020, supported by more than 100 per cent revenue and net income growth – including a strong Q1 2025 – it's down by 20 per cent year-over-year, likely discounting numerous projects near completion expected to drive growth through year-end. Olympia Financial Group Our second micro-cap stock pick, Olympia Financial (TSX:OLY), market cap C$266.57 million, last trading at C$110.78, administers self-directed registered plan accounts, corporate trusts, transfer agency services, currency exchange, global payments, private health plans and information technology services in the Canadian market. The company more than doubled revenue from C$48.62 million in 2020 to C$102.92 million in 2024, while tripling net income over the period from C$7.99 million to C$23.92 million, respectively, following this up with a steady Q1 2025 marked by a growing client base. Under the care of a long-tenured management team with 34-per-cent insider ownership, Olympia is in the midst of a multi-pronged growth plan (slide 25) to expand its established position in private markets, granting investors a data-driven thesis for meaningful gains, despite the stock adding 184 per cent since 2020. ADF Group Our final micro-cap stock to watch, ADF Group (TSX:DRX), market cap C$188.29 million, last trading at C$6.70, is a top designer and engineer of steel structures for the North American non-residential infrastructure sector. The company's over 65-year track record includes infrastructure projects spanning airports, stadiums, factories and office towers, with a current capacity to manufacture 125,000 tons of structural steel per year. If we look at ADF's past five years, we see expanding market share justified by accelerating profits. This includes revenue growth from C$172.59 million in fiscal 2021 to C$339.63 million in fiscal 2025, proven efficient by net income growth from C$6.87 million to C$56.79 million over the period. Tariff fears have since hit the stock with steep losses to the tune of 60 per cent year-over-year – most recently hampered by an increase in U.S. steel tariffs which Canada may reciprocate – with new contracts slowing and lower expected revenue and margins through the fiscal year ending January 2026. That said, the stock remains up by more than 500 per cent since 2020 – including the year-over-year loss – thanks to management's stellar operational track record. While tariff uncertainty is peaking at the moment, the high likelihood of a reasonable resolution between Canada and the U.S., given that they're commercially tied-at-the-hip, puts the profitable ADF on a path to retracing recent losses, fueled by an over C$400 million backlog as of January 2025. Should you invest in BQE Water, Olympia Financial and ADF Group today? The stocks we've discussed in this article only deserve a place in your portfolio if they match up with your financial goals, risk tolerance and time horizon. Take care to paint a clear picture of your personal financial circumstances and conduct thorough due diligence on a prospective company before putting any money to work. Join the discussion: Find out what everybody's saying about these micro-cap stocks to watch on the BQE Water Inc., Olympia Financial Group Inc. and ADF Group Inc. Bullboards and check out the rest of Stockhouse's stock forums and message boards. The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
Cision Canada
9 hours ago
- Cision Canada
Minsud Announces Option Grant
TORONTO, June 6, 2025 /CNW/ - Minsud Resources Corp. (TSXV: MSR) (" Minsud" or the " Company") is pleased to announce that it has granted options to purchase an aggregate of 600,000 common shares of the Company (the " Stock Options") to certain directors of the Company. The Stock Options are exercisable at a price of $0.60 per share for a period of five years from the date of issuance. As of the date hereof, a total of 16,494,852 common shares of the Company are reserved for issuance under the Company's stock option plan and, after this new grant, 13,876,000 options will be outstanding. About Minsud Resources Corp. Minsud is a mineral exploration company focused on exploring its flagship Chita Valley Cu-Mo-Au-Ag-Pb-Zn Project, in the Province of San Juan, Argentina. The Company's shares are listed on the TSX-V under the trading symbol "MSR", and on the OTCQX under the symbol "MDSQF". Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. SOURCE Minsud Resources Corp.
Globe and Mail
9 hours ago
- Globe and Mail
Stocks Finish Sharply Higher on a Resilient US Labor Market
The S&P 500 Index ($SPX) (SPY) Friday closed up +1.03%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +1.05%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.99%. June E-mini S&P futures (ESM25) are up +1.04%, and June E-mini Nasdaq futures (NQM25) are up +0.99%. Stock indexes rallied sharply on Friday, with the S&P 500 posting a 3-1/2 month high and the Dow Jones Industrials posting a 3-month high. Stocks settled sharply higher after Friday's better-than-expected US May employment report alleviated concerns of an economic slowdown. Also, the resumption of US-China trade talks gave stocks a boost after President Trump said that US and Chinese negotiators will resume trade talks on Monday in London. Tesla rose more than +3% Friday after plunging -14% on Thursday when President Trump proposed ending government contracts and subsidies for Elon Musk's companies. Shares of Tesla recovered Friday when Musk, who triggered the public feud by criticizing President Trump's tax bill, signaled he's keen to dial down the hostility. US May nonfarm payrolls rose +139,000, stronger than expectations of +126,000, although Apr nonfarm payrolls were revised lower to +147,000 from the previously reported +177,000. The May unemployment rate remained unchanged at 4.2%, right on expectations. US May average hourly earnings rose +0.4% m/m and +3.9% y/y, stronger than expectations of +0.3% m/m and +3.7% y/y. US Apr consumer credit rose +$17.873 billion to a 4-month high, better than expectations of +$10.000 billion. Fed comments on Friday were mixed for stocks and bonds. On the bearish side, Cleveland Fed President Hammack said she'd rather wait for further clarity on the economic impact of a variety of policy changes before adjusting interest rates, and now "is not a good time to be preemptive." Conversely, Philadelphia Fed President Harker favors the Fed waiting before cutting rates and said, "I could see in the second half of the year, if things resolve themselves, and we start to see more clarity, and we continue to see inflation coming down to 2%, I could definitely see a rate cut in the offing." The markets are discounting the chances at 0% for a -25 bp rate cut at the next FOMC meeting on June 17-18. Overseas stock markets on Friday settled higher. The Euro Stoxx 50 closed up +0.36%. China's Shanghai Composite rose to a 2-week high and closed up +0.04%. Japan's Nikkei Stock 225 closed up +0.50%. Interest Rates September 10-year T-notes (ZNU2 5) Friday closed down -28.5 ticks. The 10-year T-note yield rose +11.9 bp to 4.510%. Sep T-notes on Friday gave up an early advance and fell to a 1-week low, and the 10-year T-note yield rose to a 1-week high of 4.512%. T-notes retreated Friday on the hawkish US May payroll report that showed a larger-than-expected increase in nonfarm payrolls and a larger-than-expected increase in average hourly earnings. T-notes added to their losses Friday on hawkish comments from Cleveland Fed President Hammack, who said she'd rather wait before adjusting interest rates. T-notes on Friday initially posted modest gains on carryover strength from a rally in 10-year German bunds. European government bond yields on Friday were mixed. The 10-year German bund yield fell -0.7 bp to 2.576%. The 10-year UK gilt yield rose +2.8 bp to 4.644%. Eurozone Q1 GDP was revised higher to +0.6% q/q and +1.5% y/, stronger than expectations of +0.4% q/q and +1.2% y/y. Eurozone Apr retail sales rose +0.1% m/m, weaker than expectations of +0.2% m/m. German Apr industrial production fell -1.4% m/m, weaker than expectations of -1.0% m/m. ECB Governing Council member Stournaras said, "The bar for another ECB rate cut is high, in July and beyond," and the ECB should pause its interest rate cuts to give officials a chance to assess recent shocks, particularly from trade. Swaps are discounting the chances at 27% for a -25 bp rate cut by the ECB at the July 24 policy meeting. US Stock Movers Chip makers moved higher on Friday to boost the broader market. Marvell Technology (MRVL) closed up more than +4%. Also, Analog Devices (ADI), Micron Technology (MU), and ARM Holdings Plc (ARM) closed up more than +2%. In addition, Applied Materials (AMAT), Lam Research (LRCX), KLA Corp (KLAC), Microchip Technology (MCHP), ON Semiconductor (ON), NXP Semiconductors NV (NXPI), Texas Instruments (TXN), and Qualcomm (QCOM) closed up more than +1%. Strength in the Magnificent Seven stocks was a positive factor for the overall market. Alphabet (GOOGL) closed up more than +3%, and (AMZN) closed up more than +2%. Also, Apple (AAPL), Nvidia (NVDA), and Meta Platforms (META) closed up more than +1%. In addition, Microsoft (MSFT) closed up +0.58%. Energy stocks and energy service providers moved higher on Friday after the price of WTI crude rose more than +1% to a 1-1/2 month high. APA Corp (APA) closed up more than +3%. Also, Chevron (CVX), Exxon Mobil (XOM), Haliburton (HAL), Baker Hughes (BKR), ConocoPhillips (COP), Devon Energy (DVN), Diamondback Energy (FANG), and Schlumberger (SLB) closed up more than +2%. Tesla (TSLA) closed up more than +3% after CEO Musk signaled he would cool tensions with President Trump following Thursday's dispute that sank Tesla stock by more than -14% when Musk called for Trump's impeachment and President Trump proposed ending government contracts and subsidies for Elon Musk's companies. QXO Inc (QXO) closed up more than +13% after Wolfe Research initiated coverage on the stock with a recommendation of outperform and a price target of $44. Quanex Building Products (NX) closed up more than +10% after reporting Q2 net sales of $452.5 million, stronger than the consensus of $439.3 million. Sarepta Therapeutics (SRPT) closed up more than +9% after Scotiabank upgraded the stock to sector outperform from sector perform with a price target of $80. Lululemon Athletica (LULU) closed down more than -19% to lead losers in the S&P 500 and Nasdaq 100 after cutting its full-year EPS estimate to $14.58-$14.78 from a previous estimate of $14.95-$15.15. Docusign (DOCU) closed down more than -18% after reporting Q1 billings of $739.6 million, below the consensus of $746.4 billion, and cutting its full-year billings forecast to $3.29 billion-$3.34 billion from a previous forecast of $3.30 billion-$3.35 billion, weaker than the consensus of $3.32 billion. Vera Therapeutics (VERA) closed down more than -25% after Japanese rival Otsuka gave results from a trial of its experimental therapy for kidney disease that was better than Vera's data. ServiceTitan (TTAN) closed down more than -6% after reporting a Q1 loss per share of -51 cents, a wider loss than the consensus of -37 cents. Mosaic (MOS) closed down more than -4% after cutting its Q2 phosphates sales volume forecast to 1.5 million to 1.6 million tons from a previous forecast of 1.7 million to 1.9 million tons, well below the consensus of 1.84 million tons. Broadcom (AVGO) closed down more than -4% despite reporting better-than-expected Q2 earnings after analysts' said its future forecast isn't seen as strong enough to extend the stock's recent strength. MercadoLibre (MELI) closed down more than -3% after Citigroup opened a 30-day downside catalyst watch on the stock, citing the potential risk the company is taking to improve pricing and preserve market share. Earnings Reports (6/9/2025) Borr Drilling Ltd (BORR), Calavo Growers Inc (CVGW), Casey's General Stores Inc (CASY), Gencor Industries Inc (GENC), Graham Corp (GHM), Hooker Furnishings Corp (HOFT), Limoneira Co (LMNR), NexPoint Diversified Real Estate Trust (NXDT).
